Powered by

Lawmakers field bill that would tie U.S. drug prices to prices abroad—or threaten generic action

Nov 20, 2018 - FiercePharma

Sen. Bernie Sanders, I-Vt.,has spent years railing at the pharma industry, touting a series of proposals to control costs—each typically opposed by the industry. Now, his latest initiative aims to keep a lid on prices by threatening generic competition if drug makers charge more in the U.S. than in certain other countries.

The proposal, called the Prescription Drug Price Relief Act, directs the HHS secretary to break patents and allow generic competition when branded drugs cost more in t...